Found: 2
Select item for more details and to access through your institution.
An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).
- Published in:
- International Journal of Hematology, 2012, v. 95, n. 6, p. 652, doi. 10.1007/s12185-012-1065-2
- By:
- Publication type:
- Article
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article